Business Wire

Velodyne Lidar Announces Multi-Year Supply Agreement with TOPODRONE

21.9.2021 11:00:00 EEST | Business Wire | Press release

Share

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a multi-year agreement to provide its lidar sensors to TOPODRONE, which is based in Switzerland and develops affordable, high-precision solutions for aerial surveys. Using Velodyne lidar sensors has enabled TOPODRONE to bring high-precision mapping and 3D modeling to demanding environments including farms, forests, infrastructure and more to support development that advances economic and sustainability goals.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005316/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Velodyne Lidar announced a multi-year agreement to provide its lidar sensors to TOPODRONE, which is based in Switzerland and develops affordable, high-precision solutions for aerial surveys. Using Velodyne lidar sensors has enabled TOPODRONE to bring high-precision mapping and 3D modeling to demanding environments including farms, forests, infrastructure and more. (Photo: TOPODRONE)

Velodyne (Hall: 20, Booth: 20F.29) and TOPODRONE (Hall: 20, Booth: 20E.19) will showcase their lidar-based solutions for the geospatial community at INTERGEO 2021, a world-leading expo and conference platform for geomatics and future-oriented solutions. The event takes place in Hannover, Germany on Sept. 21 to 23.

“Velodyne’s lidar sensors enable our solutions to capture intricate, precise measurements that are essential in producing a high-quality survey,” said Maxim Baklykov, Founder and CEO, TOPODRONE, a market leader in the survey sector. “The sensors’ light weight and compact form factor provide great synergy with one of TOPODRONE’s major principles of building some of the lightest lidar-based survey solutions in the market. Velodyne’s sensors provide best in class power consumption which allows drones to fly longer. Working with Velodyne has helped us leverage their well-known brand and product quality, which adds great value and customer confidence in our solutions.”

TOPODRONE is using Velodyne’s Puck™, Puck Hi-Res™ and Ultra Puck™ as the 3D data perception and mapping sensors in its survey solutions. TOPODRONE 100 LITE and TOPODRONE 200 ULTRA are lightweight and accurate solutions that can be installed on drones, vertical take-off and landing (VTOL) unmanned aerial vehicles (UAVs) and backpack systems for mobile laser scanning. TOPODRONE 200 ULTRA, together with a Supercam SX350 VTOL, allows surveyors to cover more than 10 square kilometers per flight with high density and accurate RGB LiDAR point cloud data generated from 150 meters altitude.

TOPODRONE Delivers Precision Surveying for Customers Worldwide

TOPODRONE provides Velodyne lidar-powered scanner solutions to global markets with customers that include some of the world’s most renowned research universities. Researchers and specialists at the Natural Resources Institute Finland working on sustainable development of the Finnish bioeconomy used a TOPODRONE laser scanner mounted on a drone, quadbike and person. Even operating under hard winter conditions, such as flying under -20° C and during night, the scanner delivered high positional accuracy of collected point cloud data.

Another customer is Track Your Build, based in Sierra Leone, which offers remote sensing services for construction and infrastructure management. The company used a TOPODRONE scanner to conduct a successful topographical survey for a hydroelectric dam project. Track Your Build has now brought lidar-based surveying into its workflow for urban and rural areas to negate the need for spot elevations.

In Costa Rica, M. Eduardo Sáenz V, professional surveyor, uses TOPODRONE 100 LITE to survey forests, teak plantations, various types of farms and land for development. He commented, “The system has definitely made an impact, cutting costs and delivery times dramatically. It has proven reliable in tough working environments. The gain in time and detail are substantial. The possibilities for this tool are almost endless.”

“TOPODRONE has built an impressive global customer base by helping companies address a range of challenging mapping conditions and delivering accurate survey data,” said Erich Smidt, Vice President of Europe, Velodyne Lidar. “Their solutions demonstrate the performance and flexibility of Velodyne’s sensors by having a product family with multiple deployment modes.”

Velodyne’s lidar sensors make it quick and easy for companies to build highly accurate 3D models of any environment for mobile mapping. The sensors deliver a high-resolution, 360-degree surround view image to accurately measure and analyze the environment. The performance, range, light weight, low power consumption and compact form factor of Velodyne sensors enable developers to design versatile systems that can be configured for mobile and UAV/drone applications. Velodyne’s sensors have proven reliability, even when operating in difficult applications and weather conditions. To purchase Velodyne’s sensors, please contact Velodyne Sales at 669.275.2526, sales@velodyne.com.

About Velodyne Lidar

Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne, the global leader in lidar, is known for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality, and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com.

Forward Looking Statements

This press release contains "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, and competition. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," “can,” "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include uncertainties regarding government regulation and adoption of lidar, the uncertain impact of the COVID-19 pandemic on Velodyne's and its customers' businesses; Velodyne's ability to manage growth; Velodyne's ability to execute its business plan; uncertainties related to the ability of Velodyne's customers to commercialize their products and the ultimate market acceptance of these products; the rate and degree of market acceptance of Velodyne's products; the success of other competing lidar and sensor-related products and services that exist or may become available; uncertainties related to Velodyne's current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne's intellectual property; and general economic and market conditions impacting demand for Velodyne's products and services. For more information about risks and uncertainties associated with Velodyne’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Velodyne’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. All forward-looking statements in this press release are based on information available to Velodyne as of the date hereof, Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Velodyne Investor Relations
InvestorRelations@velodyne.com

Velodyne Media
Codeword
Liv Allen
velodyne@codewordagency.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release

Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation5.8.2026 16:37:00 EEST | Press release

Speech Processing Solutions, the global leader in AI-assisted professional dictation and documentation solutions sold under the Philips brand, today announced the Philips SpeechLive Legal AI Assistant. The new solution transforms voice recordings, dictation and uploaded sources into structured, ready-to-review legal documents, helping legal professionals work faster while retaining control of the final draft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805997413/en/ The new Philips SpeechLive Legal AI Assistant is designed for turning conversations into ready-to-review legal document drafts. SpeechLive Legal significantly reduces the time needed to transform voice input into structured legal documentation, delivering consistent and high-quality drafts and featuring SpeechLive's built-in integrations with leading case management platforms such as Actionstep, Clio, iManage and NetDocuments, supporting existing billing, e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye